Pfizer’s abuse-resistant opioid nears US market
A US Food and Drug Administration advisory panel is recommending approval of Pfizer’s abuse-resistant opioid painkiller ALO-02.
Read More
Tag: abuse-resistant
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
